Supplementary Figure 2 from Pharmacodynamic and Antineoplastic Activity of BI 836845, a Fully Human IGF Ligand-Neutralizing Antibody, and Mechanistic Rationale for Combination with Rapamycin
Year: 2023
Type: supplementary-materials
Abstract: PDF - 595KB, Correlation of rapamycin-induced AKT phosphorylation with effect of BI 836845 treatment on cell viability.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362526359